162 related articles for article (PubMed ID: 10590404)
1. Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy.
Gorson KC; Ropper AH; Adelman LS; Weinberg DH
Muscle Nerve; 2000 Jan; 23(1):37-43. PubMed ID: 10590404
[TBL] [Abstract][Full Text] [Related]
2. Demyelinating neuropathy in diabetes mellitus.
Sharma KR; Cross J; Farronay O; Ayyar DR; Shebert RT; Bradley WG
Arch Neurol; 2002 May; 59(5):758-65. PubMed ID: 12020257
[TBL] [Abstract][Full Text] [Related]
3. Sensory CIDP presenting as cryptogenic sensory polyneuropathy.
Chin RL; Latov N; Sander HW; Hays AP; Croul SE; Magda P; Brannagan TH
J Peripher Nerv Syst; 2004 Sep; 9(3):132-7. PubMed ID: 15363060
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
Jann S; Bramerio MA; Facchetti D; Sterzi R
J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy.
Uncini A; De Angelis MV; Di Muzio A; Callegarini C; Ciucci G; Antonini G; Lugaresi A; Gambi D
Clin Neurophysiol; 1999 Apr; 110(4):705-11. PubMed ID: 10378742
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.
Gorson KC; Allam G; Ropper AH
Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.
Stewart JD; McKelvey R; Durcan L; Carpenter S; Karpati G
J Neurol Sci; 1996 Oct; 142(1-2):59-64. PubMed ID: 8902721
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
Kalita J; Misra UK; Yadav RK
Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
[TBL] [Abstract][Full Text] [Related]
9. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy.
Thaisetthawatkul P; Logigian EL; Herrmann DN
Neurology; 2002 Nov; 59(10):1526-32. PubMed ID: 12451191
[TBL] [Abstract][Full Text] [Related]
10. Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy.
Sharma KR; Cross J; Ayyar DR; Martinez-Arizala A; Bradley WG
Arch Neurol; 2002 May; 59(5):751-7. PubMed ID: 12020256
[TBL] [Abstract][Full Text] [Related]
11. Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies.
Tamura N; Kuwabara S; Misawa S; Mori M; Nakata M; Hattori T
Clin Neurophysiol; 2005 Oct; 116(10):2330-3. PubMed ID: 16122982
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy.
Bosboom WM; Van den Berg LH; De Boer L; Van Son MJ; Veldman H; Franssen H; Logtenberg T; Wokke JH
Neurology; 1999 Sep; 53(4):837-45. PubMed ID: 10489051
[TBL] [Abstract][Full Text] [Related]
13. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.
Dunnigan SK; Ebadi H; Breiner A; Katzberg HD; Barnett C; Perkins BA; Bril V
PLoS One; 2014; 9(2):e89344. PubMed ID: 24586703
[TBL] [Abstract][Full Text] [Related]
14. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological demyelinating features in hereditary ATTR amyloidosis.
Ohashi N; Kodaira M; Morita H; Sekijima Y
Amyloid; 2019 Mar; 26(1):15-23. PubMed ID: 30688105
[TBL] [Abstract][Full Text] [Related]
16. Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders.
Bromberg MB; Albers JW
Muscle Nerve; 1993 Mar; 16(3):262-6. PubMed ID: 8383290
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy.
Notermans NC; Franssen H; Eurelings M; Van der Graaf Y; Wokke JH
Muscle Nerve; 2000 Jan; 23(1):73-9. PubMed ID: 10590408
[TBL] [Abstract][Full Text] [Related]
18. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
[TBL] [Abstract][Full Text] [Related]
20. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
